Cognition Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
Aug 26 (Reuters) - Cognition Therapeutics Inc CGTX.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.